Advertise With UsAdvertise on our extensive network of industry websites and newsletters.
Get the PBR newsletterSign up to our free email to get all the latest PBR
news.Goodwin Biotechnology has entered into a biopharmaceutical development and manufacturing agreement with a multinational biopharmaceutical client, under which Goodwin will be responsible for the development of the process to manufacture a therapeutic monoclonal antibody conjugate for diagnostic imaging purposes.
Subscribe to our email newsletter
The product is expected to be manufactured under cGMP conditions as a kit for radio-labeling for use in clinical trials.
Goodwin operations senior vice president SooYoung Lee said that they have recently seen a strong interest in bio-conjugations from the biopharmaceutical industry to develop improved imaging and therapeutic biologic compounds.
"Most of our customers are looking for one stop shop type of CMO services that will provide development, bulk production, characterisation and fill/finish at one location," Lee said.
Goodwin Biotechnology is a full service contract biomanufacturing company and specialises in process development and cGMP production of protein based therapeutics and bio-conjugations for pre-clinical and early phase clinical trials.